The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial registered on ANZCTR


Registration number
Help: Registration number
ACTRN12626000885392
Ethics application status
Help: Ethics application status
Approved
Date submitted
Help: Date submitted
3/07/2026
Date registered
Help: Date registered
17/07/2026
Date last updated
Help: Date last updated
17/07/2026
Date data sharing statement initially provided
Help: Data sharing statement date
17/07/2026
Type of registration
Help: Type of registration
Prospectively registered

Titles & IDs
Public title
Nerve Block Pain Relief for Older People with Multiple Rib Injuries: An Evaluation
Scientific title
Evaluation of fascial plane regional anaesthesia techniques for pain management in elderly patients with multiple rib fractures
Additional trial identifiers [1] 317784 0
Nil
Universal Trial Number (UTN)
Trial acronym
Related trial records

Health condition
Health condition(s) studied:
Rib Fractures 342693 0
Condition category
Condition code
Injuries and Accidents 338834 338834 0 0
Other injuries and accidents
Anaesthesiology 339016 339016 0 0
Pain management

Intervention/exposure
Study type
Observational
Patient registry
False
Target follow-up duration
Target follow-up type
Description of the intervention or exposure
The study will conduct a retrospective review of approximately 350 electronic medical records, for the period between January 2020 and December 2025, of patients aged 65 years and older, who sustained unilateral multiple rib fractures, and were referred to the Acute Pain Service (APS) for ongoing pain management. Each patient record will be reviewed to gather data on demographics, admission details, clinical presentation, pain management strategies, clinical outcomes, as well as functional and discharge outcomes. 
Following data collection, patient demographic and clinical characteristics will be summarised and examined in relation to pain scores, patterns of analgesic use, and other relevant clinical outcomes. Primary and secondary outcomes will be compared between patients who received regional anaesthesia and those managed with multimodal analgesia alone. Descriptive statistics, including means, standard deviations, medians, interquartile ranges, frequencies, and percentages, will be used as appropriate to summarise explanatory variables and outcome measures. Multivariable linear and logistic regression analyses will be undertaken to evaluate associations between key patient characteristics (including age, sex, admission functional status, and fracture site) and clinical outcomes such as pain intensity, analgesic requirements, respiratory function, incidence of pneumonia, discharge functional status, and length of stay in hospital and the intensive care unit (ICU).
Intervention code [1] 334629 0
Diagnosis / Prognosis
Description of the comparator or control
The outcomes will be compared with those of a matched cohort managed exclusively with multimodal analgesia during the period between January 2020 and December 2025, of patients aged 65 years and older,without the use of any regional anaesthetic or analgesic techniques.
Control group
Historical

Outcomes
Primary outcome [1] 346040 0
Pain
Timepoint [1] 346040 0
baseline, 24 hours and 48hours and 72 hours post insertion of the regional block catheter
Primary outcome [2] 346041 0
Analgesia requirement
Timepoint [2] 346041 0
Data will be collected at predefined timepoints: baseline (prior to regional block catheter insertion), 24 hours post-insertion, 48 hours post-insertion, and 72 hours post-insertion, to enable comparison of outcomes over time
Secondary outcome [1] 464414 0
Incidence of pneumonia
Timepoint [1] 464414 0
assessed by daily review of the electronic medical record throughout the patient's hospital stay. Pneumonia will be identified based on documented clinical diagnosis and supporting evidence from vital signs, blood test results, radiological investigations, and treatment records.
Secondary outcome [2] 464415 0
Functional status
Timepoint [2] 464415 0
baseline, 24 hours, 48 hours and 72 hours post regional block palacement
Secondary outcome [3] 464416 0
Admission to Intensive Care Unit
Timepoint [3] 464416 0
Throughout the hospital stay
Secondary outcome [4] 464417 0
Lenghth of Stay in hospital(LOS)
Timepoint [4] 464417 0
Hospital length of stay will be derived from the recorded admission and discharge dates of the relevant inpatient episode.

Eligibility
Key inclusion criteria
Age greater than or equal to 65 years
Maximum age: No limit
Sex: Both males and female patients
Hospital admission for acute unilateral rib fractures confirmed by computed tomography (CT) imaging
Referral to the Acute Pain Service (APS) for pain management
Minimum age
65 Years
Maximum age
No limit
Sex
Both males and females
Healthy volunteers
No
Key exclusion criteria
• Age less than 65 years
• Bilateral rib fractures

Study design
Purpose
Screening
Duration
Selection
Timing
Statistical methods / analysis

Recruitment
Recruitment status
Not yet recruiting
Date of first participant enrolment
Anticipated
Actual
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
Sample size
Target
Accrual to date
Final
Recruitment in Australia
Recruitment state(s)
NSW

Funding & Sponsors
Funding source category [1] 322328 0
Government body
Name [1] 322328 0
The Australian Government Research Training Program (RTP)
Country [1] 322328 0
Australia
Primary sponsor type
University
Name
Western Sydney University
Address
Country
Australia
Secondary sponsor category [1] 325246 0
Government body
Name [1] 325246 0
South Western Sydney Local Hralth District
Address [1] 325246 0
Country [1] 325246 0
Australia

Ethics approval
Ethics application status
Approved
Ethics committee name [1] 320830 0
South Western Sydney Local Health District Human Research Ethics Committee
Ethics committee address [1] 320830 0
Ethics committee country [1] 320830 0
Australia
Date submitted for ethics approval [1] 320830 0
19/12/2025
Approval date [1] 320830 0
23/06/2026
Ethics approval number [1] 320830 0

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 151778 0
Ms Maja Kottayil
Address 151778 0
Bankstown Lidcombe Hospital, 68-70 Eldridge Road, Bankstown, NSW 2200
Country 151778 0
Australia
Phone 151778 0
+61470622759
Fax 151778 0
Email 151778 0
Contact person for public queries
Name 151779 0
Maja Kottayil
Address 151779 0
Bankstown Lidcombe Hospital,68-70 Eldridge Road, Bankstown, NSW 2200
Country 151779 0
Australia
Phone 151779 0
+61 2 9722 8655
Fax 151779 0
Email 151779 0
Contact person for scientific queries
Name 151780 0
Maja Kottayil
Address 151780 0
Bankstown Lidcombe Hospital,68-70 Eldridge Road, Bankstown, NSW 2200
Country 151780 0
Australia
Phone 151780 0
+61 2 9722 8655
Fax 151780 0
Email 151780 0

Data sharing statement
Will the study consider sharing individual participant data?
No


What supporting documents are/will be available?

No Supporting Document Provided


Results publications and other study-related documents

Documents added manually
No documents have been uploaded by study researchers.

Documents added automatically
No additional documents have been identified.